News Mallinckrodt pays US authorities $100m in pricing case Price of epilepsy drug increased 85,000% since 2001, says FTC.
News Outlook bright for Vertex despite European delays But analysts excited by promise of next generation of medicines.
News Alexion drug fails in kidney transplant trial Soliris fails when used to treat post-transplant complications.
News Sarepta files controversial Duchenne drug in EU US biotech seeks conditional approval for eteplirsen in EU.
News Intercept's Ocaliva approved in EU for liver disease Potential liver blockbuster gets EU licence.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
